HERITAGE INVESTORS MANAGEMENT CORP
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 937589
BETHESDA, MD
Position in TAK
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$1,821,238
+$279,824 QoQ
Shares Held
98,339
-0.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HERITAGE INVESTORS MANAGEMENT CORP holds $32,059,665 across 5 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
209,297 | $24,740,998 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
126,831 | $3,035,065 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
98,339 | $1,821,238 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
50,960 | $1,534,915 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
7,040 | $927,449 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,821,238 | 98,339 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,541,414 | 98,872 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,462,126 | 99,872 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,594,065 | 103,109 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,537,245 | 103,379 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,411,767 | 106,629 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,624,620 | 114,249 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,492,616 | 115,349 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,627,477 | 117,169 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,689,125 | 118,369 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,909,910 | 123,459 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,033,439 | 129,436 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,569,347 | 155,907 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $2,682,310 | 171,943 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,457,983 | 189,513 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $3,261,253 | 232,283 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,411,568 | 238,238 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,466,449 | 254,325 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $6,216,422 | 379,513 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $6,108,398 | 362,947 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $5,916,769 | 324,029 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,909,649 | 324,706 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $5,727,228 | 321,033 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $5,531,082 | 308,482 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $4,603,486 | 303,260 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||